Ischemic Memory Imaging: The Quest for the Holy Grail Continues

For patients presenting with acute chest pain, current clinical evaluation rests upon history, physical examination, surface electrocardiography, and serum cardiac biomarkers. The evolution of the latter, particularly toward high-sensitivity troponin assays, has dramatically increased the detection of smaller infarcts, allowed much earlier diagnoses, and improved risk stratification.1,2 Despite this widespread adoption, the clinical entity of “unstable angina” (UA), whereby supply-demand mismatch occurs but ischemic time is not sufficient to cause myocyte necrosis and biomarker release, remains a real and challenging entity.

Source: Journal of the American Society of Echocardiography - October 31, 2019 Category: Cardiology Authors: Yin Ge, Howard Leong-Poi Tags: Editorial Comment Source Type: research